Evaluation of the activity of bispirazoles against recombinant Trypanosoma cruzi strains expressing ß-galactosidase
Background: Nifurtimox and benznidazole are the only drugs currently approved to treat Chagas disease, caused Trypanosoma cruzi. However, they display unsatisfactory efficacy and induce undesirable side effects. Therefore, identifying new compounds with specific activity against T. cruzi is of great...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://repositorio.puce.edu.ec/handle/123456789/43351 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag Be the first to leave a comment!